The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. From Wikipedia
The order directs sweeping changes to Medicare negotiations, drug pricing transparency, and affordability programs, with implementation dependent on future legislative and regulatory actions.
